DAL PRA, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 1.751
AS - Asia 277
EU - Europa 270
OC - Oceania 1
Totale 2.299
Nazione #
US - Stati Uniti d'America 1.742
CN - Cina 164
SG - Singapore 71
IT - Italia 63
FI - Finlandia 50
UA - Ucraina 42
DE - Germania 36
SE - Svezia 25
VN - Vietnam 18
FR - Francia 17
IN - India 17
GB - Regno Unito 12
IE - Irlanda 12
CA - Canada 9
BE - Belgio 5
LU - Lussemburgo 3
TR - Turchia 3
NL - Olanda 2
AU - Australia 1
BN - Brunei Darussalam 1
CZ - Repubblica Ceca 1
GE - Georgia 1
GR - Grecia 1
KR - Corea 1
PH - Filippine 1
RU - Federazione Russa 1
Totale 2.299
Città #
Fairfield 222
Chandler 188
Jacksonville 168
Ashburn 134
Woodbridge 133
Seattle 110
Cambridge 95
Houston 91
Wilmington 78
Beijing 66
Ann Arbor 61
Princeton 56
Singapore 51
Helsinki 30
San Diego 26
Medford 25
Roxbury 22
Nanjing 21
Padova 19
Des Moines 18
Dong Ket 18
New York 14
Boardman 12
Dublin 11
Santa Clara 10
Pune 9
Guangzhou 8
Hebei 7
Jinan 7
Renton 7
Nanchang 6
Newmarket 6
Tianjin 6
Frankfurt am Main 4
Los Angeles 4
Redwood City 4
Shenyang 4
Teramo 4
Brendola 3
Changsha 3
Dallas 3
Hangzhou 3
Jiaxing 3
Ningbo 3
Rivignano 3
Acerra 2
Ankara 2
Arcole 2
Borås 2
Cascina 2
Dalmine 2
Haikou 2
Hefei 2
Kunming 2
Lier 2
London 2
Luxembourg 2
Milan 2
Modena 2
North Charleston 2
Ogden 2
Phoenix 2
Schaarbeek 2
Acton 1
Amsterdam 1
Bandar Seri Begawan 1
Bend 1
Brescia 1
Brno 1
Brussels 1
Caherdaniel 1
Easton 1
Fort Worth 1
Fuzhou 1
Gallarate 1
Groningen 1
Indiana 1
Kayseri 1
Kharkiv 1
Lanzhou 1
Las Vegas 1
Livingston 1
Manila 1
Melbourne 1
Miami 1
Mountain View 1
Ottawa 1
Rockville 1
Seongnam-si 1
Shanghai 1
Taizhou 1
Tbilisi 1
Thessaloníki 1
Trento 1
Treviso 1
Vancouver 1
Venezia 1
Washington 1
Totale 1.847
Nome #
Modifications of Resting Energy Expenditure After Sleeve Gastrectomy 195
SCCA-IgM as a Potential Biomarker of Non-Alcoholic Fatty Liver Disease in Patients with Obesity, Prediabetes and Diabetes Undergoing Sleeve Gastrectomy 176
Characterization of subcutaneous and omental adipose tissue in patients with obesity and with different degrees of glucose impairment 142
Resting Energy Expenditure, Insulin Resistance and UCP1 Expression in Human Subcutaneous and Visceral Adipose Tissue of Patients With Obesity 90
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 89
Pancreatic Autoantibodies in Italian Patients with Newly Diagnosed Type 1 Diabetes Mellitus under the Age of 20 Years. 87
Mechanism of inhibition of cytochrome P450C21 enzyme activity by autoantibodies from patients with Addison's disease 80
Gonadotrophin receptor blocking antibodies measured by the use of cell lines stably expressing human gonadotrophin receptors are not detectable in women with 46,XX premature ovarian failure 79
Estimation of serum TSH receptor autoantibody concentration and affinity. 79
Estimated risk for developing autoimmune Addison's disease in patients with adrenal cortex autoantibodies. 78
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study 74
Autoantibodies to steroidogenic enzymes in patients with premature ovarian failure with and without Addison's disease 71
Modifications of Resting Energy Expenditure after surgical or medical weight loss: Is there any difference? 68
Autoantibodies to human tryptophan hydroxylase and aromatic L-amino acid decarboxylase. 66
Assessment of adrenal function and adrenal autoantibodies in a baby of a mother with autoimmune polyglandular syndrome type 2. 63
Direct evidence that steroid 21-hydroxylase (21-OH) is the major antigen recognized by adrenal cortex autontibodies (ACA) 61
Obesity and COVID-19: an Italian snapshot 61
Adrenal cortex antibodies: long-term follow-up 59
"UCP1 mRNA expression in human subcutaneous and visceral adipose tissue during the progression from obesity to diabetes" 56
Autoimmunity in isolated Addison's disease and in polyglandular autoimmune diseases type 1, 2 and 4 53
Autoantibodies to steroidogenic enzymes in patients with premature ovarian failure 52
Effect of Bariatric Surgery on Non-alcoholic fatty liver disease 49
Association of obstructive sleep apnea with non-alcoholic fatty liver disease in patients with obesity: an observational study 48
Estimating the of autoimmune Addison's disease 47
Antibody targets in utoimmune Addison's disease 46
Metabolic flexibility after bariatric surgery-induced weight loss: does diabetes impair a proper substrates utilization? 45
Shock anafilattico dopo ingestione di miele grezzo (“raw-honey”): sensibilizzazione a pollini o a veleno d'api? 44
HLA-DR and DQ associations with autoimmune Addison's disease in Italian patients 41
Resting energy expenditure is associated with insulin resistance and inflammatory status before and after weight loss in patients with severe obesity 39
Autoantibodies to steroidogenic enzymes in patients with idiopathic premature ovarian failure 37
Improvement of lipid profile after one‐anastomosis gastric bypass compared to sleeve gastrectomy 37
21-hydroxylase is the major target of adrenal cortex autoantibodies (ACA) in patients with different clinical forms of autoimmune Addison's disease 36
Sera from patients with idiopathic premature ovarian failure do not affect the function of the FSH and LH receptors 26
Higher levels of C-reactive protein and ferritin in patients with overweight and obesity and SARS-CoV-2-related pneumonia 25
Autoimmune Adrenal Insufficiency and Autiooimmune Polyendocrine Syndromes: Autoantibodies, Autoantigens, and Their applicability in Diagnosis and Disease Prediction. Endocrine Reviews 22
Totale 2.321
Categoria #
all - tutte 8.457
article - articoli 6.214
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.671


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020449 0 0 0 82 37 29 40 47 50 89 48 27
2020/2021418 14 49 41 31 11 22 9 39 44 71 41 46
2021/2022332 8 44 23 20 25 15 11 39 28 4 28 87
2022/2023407 83 43 8 46 57 57 0 26 57 1 24 5
2023/2024247 7 33 36 21 17 43 12 25 7 10 10 26
2024/2025124 3 72 33 16 0 0 0 0 0 0 0 0
Totale 2.321